SUPPORTING MATERIAL

METHODS
Purification of Human Syt I C2A Human Syt I C2A was purified as a glutathione S-transferase (GST) fusion protein using affinity chromatography, followed by removal of the GST domain. The KG-C2A plasmid was transformed into BL21-DE3 competent Escherichia coli cells and the DNA was sequenced (Northwoods DNA, Inc., Bemidji, MN). 5.0ml starter cultures in LB Broth (overnight growth at 37°C) were used to inoculate 1L LB Broth cultures. These 1L cultures were incubated at 37°C in the presence of 100μg/ml ampicillin until an optical density of 0.8-1.4 was reached (~5h). After induction with 1.0mM isopropyl β-D-1-thiogalactopyranoside, the cultures were incubated at 37°C for an additional 5h. The cells were harvested by centrifugation. 20g of the cell pellet was lysed by sonication in 20mM MOPS, 100mM KCl, pH 7.5 using Complete EDTA-free protease inhibitor tablets (Roche). Following lysis, cellular debris was pelleted by centrifugation (30min at 16,000rpm). The supernatant was treated with benzonuclease (10units/ml in the presence of 5.0mM magnesium chloride) for at least 8h. Host DNA was separated by centrifugation (45min at 20,000rpm) followed by sterile filtering with a 0.4μm filter. The C2A-GST fusion protein was allowed to bind 50.0ml of equilibrated GST-affinity resin for 2h at 4°C. Elution of nonspecific host proteins was achieved using 500ml of lysis buffer. (Complete elution was confirmed by monitoring the A280 via Nanodrop (Thermo Scientific).) The media was re-suspended using 30ml of 6.0μg/ml thrombin solution (in lysis buffer) and allowed to rock at room temperature for 6h. After cleavage of the GST domain, free C2A and thrombin were eluted from the column with lysis buffer. (Again, complete elution was confirmed by monitoring the A280.) The protein solution was rocked overnight in the presence of 2μl/ml p-aminobenzamidine-agarose media (Sigma) to remove thrombin; the media was then separated from the protein solution by centrifugation (15min at 3000rpm) and sterile filtering with a 0.4μm filter. The resulting protein solution was re-passed over a clean GST-resin column as needed to ensure separation of any contaminating GST. Recombinant C2A was dialyzed in the presence of Chelex-100 resin to remove any contaminating Ca 2+ by batch method and concentrated to ~50μM using concentrator units (Amicon) with a 10kDa cutoff. Final purity was determined to be >95% by SDS-PAGE densitometry. Final concentrations were determined using a Nanodrop with an A280 extinction coefficient of 12090cm -1 M -1 .
Preparation of Carboxyfluorescein Encapsulated Vesicles
Lipid samples for carboxyfluorescein release assays were prepared using 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (18:0,18:1PC) and 1-stearoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (18:0,18:1PS) purchased from Avanti Polar Lipids and used without further purification. Samples were prepared to a final total lipid concentration of 5 mM with a composition of 80:20 18:0,18:1PC:18:0,18:1PS. The samples were dried, resuspended in benzene/methanol, and lyophilized as above. The samples were then hydrated in 500 μL of carboxyfluorescein buffer (20mM MOPS, 100mM KCl, 0.02% NaN 3 , and 50mM 5-(and-6)-carboxyfluorescein (Invitrogen), pH 7.5) to form multilamellar vesicles (MLVs). The hydrated lipid samples were then extruded using a 0.2μm pore size filter to form LUVs. These vesicles were run through a Sephadex G-25 column previously equilibrated with an equiosmolar column equilibration buffer (20mM MOPS, 100mM KCl, 0.02% NaN 3 , pH 7.5) to separate LUVs from external CF buffer. Integrity of the collected fractions was checked by thin layer chromatography by spotting on a silica gel chromatography plate and imaging with Zindade's reagent (1-4).
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